Dali Pharmaceutical Co (SHSE:603963) Days Sales Outstanding : 10.41 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Days Sales Outstanding?

Dali Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥1.75 Mil. Dali Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥15.32 Mil. Hence, Dali Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 10.41.

The historical rank and industry rank for Dali Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:603963' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.24 Med: 19.14 Max: 32.43
Current: 21.8

During the past 12 years, Dali Pharmaceutical Co's highest Days Sales Outstanding was 32.43. The lowest was 0.24. And the median was 19.14.

SHSE:603963's Days Sales Outstanding is ranked better than
92.18% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.69 vs SHSE:603963: 21.80

Dali Pharmaceutical Co's Days Sales Outstanding declined from Mar. 2023 (17.36) to Mar. 2024 (10.41).

Dali Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Dali Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co Days Sales Outstanding Chart

Dali Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

32.43

23.15

18.89

21.54

19.38

Dali Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															17.36	24.43	32.19	18.49	10.41

Competitive Comparison of Dali Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dali Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's Days Sales Outstanding falls into.

Dali Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dali Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7.577	+	1.689)	/	2 )	/	87.27	*	365
=	4.633					/	87.27	*	365
=	19.38

Dali Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1.689	+	1.807)	/	2 )	/	15.32	*	365 / 4
=	1.748					/	15.32	*	365 / 4
=	10.41

Dali Pharmaceutical Co (SHSE:603963) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Dali Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Dali Pharmaceutical Co (SHSE:603963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000

Website

http://www.daliyaoye.cn

Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

Executives

Wu Pei Rong	senior management
Yang Jun Xiang	Directors, senior managers
Yang Jun Wei	Director

Dali Pharmaceutical Co (SHSE:603963) Headlines

No Headlines